Eli Lilly’s Retatrutide Obesity Drug Achieves Landmark Weight Loss in Phase 3 Trial
Eli Lilly's retatrutide, a next-generation weight loss drug, cleared a crucial Phase 3 obesity trial, showing significant weight loss and bringing the company closer...